Skip to main content

PPBT · Purple Biotech Ltd. · Financials

Track PPBT — free
$1.56 +0.07 (+4.70%) At close · Nov 12
Market Cap
$2.54M
Shares
1.63M
Volume · Nov 12 67.46K Avg daily vol (3M) 1.24M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$1M 0%
FY2020 Revenue FY2017–FY2020
Net Income
-$26.39M -264.4%
FY2025 Net Income FY2015–FY2025
Operating Margin
-1261.2% -545.6pp
FY2020 Operating Margin FY2017–FY2020
Diluted EPS
$0.03 -99.9%
FY2025 Diluted EPS FY2021–FY2025
Operating Cash Flow
-$5.66M +60.6%
FY2025 Operating Cash Flow FY2015–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015
— — — — — $1M $1M $1M $100K — —
$3.73M $7.62M $17.03M $16.32M $11.83M $7.24M $2.28M $5.27M $4.64M $4.18M $2.56M
— — — $1.64M $1.53M $1.89M $1.04M $227K $6.33M $3M $1.51M
— — — — $6.11M $6M $4.39M — — — —
$203K $186K $199K $201K $231K $235K $178K $7000 $4000 $2000 $1000
— — -$22.27M -$22.6M -$17.93M -$12.61M -$7.16M -$7.83M -$11.97M -$7.18M -$4.07M
— — — — — -1261.2% -715.6% -782.6% -11966% — —
— — -$22.07M -$22.4M -$17.7M -$12.38M -$6.98M -$7.82M -$11.96M -$7.18M -$4.07M
$982K $483K $2.2M $67K -$212K $61K $181K $576K $26K $61K $227K
— — — — — — $216K — — — —
-$26.39M -$7.24M -$19.88M -$21.67M $18.38M $28M $5.85M $5.2M $12.18M $12.13M $4.2M
— — — — — 2799.9% 585% 520% 12177% — —
USD/shares $0.03 $44.40 $179.60 $239.70 $3,513,607,200.00 — — — — — —
USD/shares $0.03 $49.90 $179.60 $239.70 $3,513,607,200.00 — — — — — —
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Lease liabilities 2025-12-31 USD 244,000 20-F filed 2026-03-19
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current lease liabilities
USD 244,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1614744 CUSIP 74638P307 13F (30d) 8 filings 8 filers Visit website Investor relations